Vyriad

0 followers

Vyriad is developing the next generation of targeted cancer therapies using engineered viruses that selectively attack cancer cells and ignite robust immune responses to prevent cancer recurrence.

Industries

Employees

51-200

Links


Org chart

Stephen J. Russell
Co-Founder & CEO
Collapse
Catherine Benson
Director of Legal
Dr Alice Bexon
Chief Medical Officer
Joel Dickson
Supply Chain Manager
Kirstin Garner
Human Resources Manager
Sheri Tran
Sr Director of Quality and Compliance
Luke Russell, Ph.D
Director, Business Development and Strategic Alliances
Heather Bakalyar
Senior Director Of Intellectual Property
Alice S. Bexon
Chief Medical Officer

Board & advisors

Harry Stine
Board Member
James Hampton
Member Board Of Directors
Edwin Kania
Chairman